Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
- PMID: 34688435
- PMCID: PMC8530466
- DOI: 10.1016/S2213-2600(21)00458-6
Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
Conflict of interest statement
DMA and RJB receive support from the UK Medical Research Council (MR/S019553/1, MR/R02622X/1, MR/V036939/1, and MR/W020610/1) and the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre Institute for Translational Medicine and Therapeutics; Cystic Fibrosis Trust Strategic Research Centre (2019SRC015); NIHR Efficacy and Mechanism Evaluation Fast Track (NIHR134607); NIHR Long Covid (COV-LT2-0027); Innovate UK (SBRI 10008614); and Horizon 2020 Marie Skłodowska-Curie Innovative Training Network European Training Network (no. 860325). Both authors are members of the Global T cell Expert Consortium and have consulted for Oxford Immunotec, outside of the submitted work.
Comment on
-
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?Lancet Respir Med. 2021 Dec;9(12):1450-1466. doi: 10.1016/S2213-2600(21)00407-0. Epub 2021 Oct 21. Lancet Respir Med. 2021. PMID: 34688434 Free PMC article. Review.
References
-
- Dolgin E. COVID vaccine immunity is waning — how much does that matter? Nature. 2021;597:606–607. - PubMed
-
- The Irish Times Science uncertain about need for vaccine boosters, WHO says. Aug 18, 2021. https://www.irishtimes.com/news/health/science-uncertain-about-need-for-...
-
- Edridge AWD, Kaczorowska J, Hoste ACR, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020;26:1691–1693. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous